VTD Followed By MPT Maintenance As a First Line Treatment For The Patients With MM Who Are Non-Transplant Candidates
PHASE2CompletedINTERVENTIONAL
Enrollment
35
Participants
Timeline
Start Date
April 30, 2006
Primary Completion Date
February 29, 2008
Study Completion Date
February 29, 2008
Conditions
Multiple Myeloma
Interventions
DRUG
Velcade
Trial Locations (1)
405-220
Gachon University Gil Hospital, Inchon
All Listed Sponsors
collaborator
Janssen-Cilag Ltd.
INDUSTRY
lead
Korean Multiple Myeloma Working Party
OTHER
NCT00320476 - VTD Followed By MPT Maintenance As a First Line Treatment For The Patients With MM Who Are Non-Transplant Candidates | Biotech Hunter | Biotech Hunter